Actively Recruiting
The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction
Led by Ahram Canadian University · Updated on 2024-06-04
60
Participants Needed
1
Research Sites
1 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating how body mass index (BMI) affects the activity of the gluteus maximus muscle in adults who have sacroiliac joint dysfunction (SIJD). SIJD involves abnormal movement or position of the sacroiliac joint and can cause pain, contributing to 15-30% of low back pain cases. This observational study aims to add important knowledge to physical therapy by exploring this relationship. Participants are divided into two groups based on their BMI: one with BMI less than 25 and another with BMI greater than 25. The study uses electromyography (EMG) to measure gluteus maximus muscle activity. The study period includes up to 8 weeks for measuring muscle activity, BMI calculated from weight and height, and pain assessed using a visual analogue scale. During the study, participants will undergo EMG assessments to record muscle activity and have their BMI calculated from their height and weight. Pain levels will also be tracked using a visual scale. Researchers will monitor these factors for up to 8 weeks to understand how BMI may influence muscle activity in adults with sacroiliac dysfunction. The study is conducted by Ahram Canadian University and includes adults aged 20 to 40 years.
CONDITIONS
Brief Title
The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 20 to 40 years
- Diagnosed with sacroiliac dysfunction
- Body mass index between 20 and 30 kg/m2
- Experiencing mild to moderate sacroiliac pain
- Have had sacroiliac pain for at least one month
You will not qualify if you...
- History of inflammatory diseases or rheumatic disorders
- History of vertebral fractures
- Previous surgical spinal fixation
- Any neurological disorders such as multiple sclerosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 8 weeks
Participants undergo electromyography (EMG) to measure gluteus maximum muscle activity and assessments of weight, height, and pain levels.
Assessments occur up to 8 weeks
Trial Site Locations
Total: 1 location
1
Ahram Canadian university
Giza, Egypt, 12573
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here